Join the Spinal Spasticity group to help and get support from people like you.
Spinal Spasticity News
AI Can Help Track MS Progression
MONDAY, May 19, 2025 — Artificial intelligence (AI) can help detect when a person’s multiple sclerosis (MS) has reached an advanced state, a new study says. A newly developed AI correctly judged with ...
Experimental Drug Can Slow MS Disability
WEDNESDAY, April 9, 2025 – An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial...
AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS
WEDNESDAY, April 9, 2025 – Tolebrutinib, a brain-penetrant and bioactive Bruton tyrosine kinase inhibitor that modulates persistent immune activation within the central nervous system, slows...
Higher Fish Intake Linked to Reduced Risk for MS Disability Worsening
FRIDAY, Feb. 28, 2025 – Higher fish consumption is associated with slower disability progression in multiple sclerosis (MS), according to a study published online Feb. 25 in the Journal of...
MS Patients May Benefit From Eating More Fish
WEDNESDAY, Feb. 26, 2025 – A diet rich in fish might slow the progression of multiple sclerosis in some patients, a new study says. The nutrients found in fish can quell inflammation and protect...
Pregnancy Increases Mental Health Risk in MS Patients
THURSDAY, Jan. 23, 2025 – Pregnancy increases the risk of mental illness among women with multiple sclerosis (MS). Pregnant MS patients have a higher risk of mental illness both during gestation and...
Parents' Smoking Could Raise Risk for MS in Kids
WEDNESDAY, Dec. 11, 2024 – For children genetically predisposed to develop multiple sclerosis (MS), exposure to cigarette smoke in the family home could raise that risk even higher, new research...
Social Determinants of Health Linked to Brain MRI Outcomes in Pediatric MS
MONDAY, Dec. 2, 2024 – For patients with pediatric-onset multiple sclerosis (POMS), social determinants of health (SDOH) are associated with worse brain magnetic resonance imaging (MRI) outcomes,...
Generic Medications Can Keep OOP Costs Down for Neurological Conditions
WEDNESDAY, Oct. 30, 2024 – Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according...
FDA Approves Injectable Ocrevus Zunovo for Relapsing, Progressive MS
THURSDAY, Sept. 26, 2024 – The U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and only twice-a-year, 10-minute subcutaneous injection...
Could Having MS Help Shield Against Alzheimer's Disease?
TUESDAY, Aug. 27, 2024 – People with multiple sclerosis appear to have a lower risk of developing Alzheimer’s disease, a new study suggests. MS patients are far less likely to have elevated blood l...
Most Patients With MS Have No Risk for Relapse After COVID-19 Vaccination
WEDNESDAY, Aug. 14, 2024 – For most patients with multiple sclerosis (MS), there is no increased risk for relapse after COVID-19 vaccination, according to a study published online Aug. 14 in...
Most Patients With MS Have No Risk for Relapse After COVID-19 Vaccination
WEDNESDAY, Aug. 14, 2024 – For most patients with multiple sclerosis (MS), there is no increased risk for relapse after COVID-19 vaccination, according to a study published online Aug. 14 in...
Ipsen Biopharmaceuticals, Inc. Announces FDA Approval of Dysport (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Pediatric Patients Aged Two and Older
BASKING RIDGE, N.J., Aug. 1, 2016 /PRNewswire/ – Ipsen Biopharmaceuticals, Inc., a subsidiary of Ipsen SA (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that the U.S. Food and Drug...